Investigations of biomarkers of DHD and their applications have significantly progressed
PlexusDx GLP-1 medications work alongside existing metformin therapy without replacing it
Physiological and Molecular Aspects of Cobalamin Transport. Sub-Cellular Biochemistry, vol
Maintaining dietary changes and physical activity established during treatment can help minimise weight regain
This dual GLP-1 and GIP receptor agonist, licensed in the UK for type 2 diabetes and weight management, can cause dizziness through several mechanisms including blood glucose fluctuations, blood pressure changes, and gastrointestinal effects leading to dehydration
In addition to the stomach pain it can also cause cramping, bloating, aching, and gas pain (a dull and sharp occasional pain)